IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

44 hedge funds and large institutions have $222M invested in Impel Pharmaceuticals Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$4.06M
2 +$3.78M
3 +$2.44M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.2M
5
DA
DCF Advisers
Connecticut
+$1.83M

Top Sellers

1 -$2.02M
2 -$394K
3 -$240K
4
WP
Woodline Partners
California
-$238K
5
ZP
Zimmer Partners
New York
-$221K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$50.4M
2
$37.5M
3
$35.1M
4
$35.1M
5
$33.6M
6
$4.44M
7
$4.02M
8
$3.78M
9
$3.27M
10
$2.44M
11
$1.83M
12
$1.69M
13
$1.57M
14
$1.44M
15
$1.22M
16
$979K
17
$615K
18
$615K
19
$574K
20
$419K
21
$305K
22
$244K
23
$174K
24
$163K
25
$139K